These findings underscore the multifaceted tumor-suppressive functions of INTS6, primarily through cell-cycle arrest mediated by transcriptional regulation and support its therapeutic relevance in malignancies driven by aberrant CDK9 signaling. The gene discussed is CDK9; the disease is neoplasm.